Author Correction: A new antibiotic traps lipopolysaccharide in its intermembrane transporter.

Autor: Pahil KS; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA., Gilman MSA; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA., Baidin V; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA., Clairfeuille T; Departments of Immunology, Infectious Disease and Ophthalmology (I2O), Medicinal Chemistry and Lead Discovery, Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Mattei P; Departments of Immunology, Infectious Disease and Ophthalmology (I2O), Medicinal Chemistry and Lead Discovery, Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Bieniossek C; Departments of Immunology, Infectious Disease and Ophthalmology (I2O), Medicinal Chemistry and Lead Discovery, Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Dey F; Departments of Immunology, Infectious Disease and Ophthalmology (I2O), Medicinal Chemistry and Lead Discovery, Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Muri D; Departments of Immunology, Infectious Disease and Ophthalmology (I2O), Medicinal Chemistry and Lead Discovery, Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Baettig R; Departments of Immunology, Infectious Disease and Ophthalmology (I2O), Medicinal Chemistry and Lead Discovery, Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Lobritz M; Departments of Immunology, Infectious Disease and Ophthalmology (I2O), Medicinal Chemistry and Lead Discovery, Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Bradley K; Departments of Immunology, Infectious Disease and Ophthalmology (I2O), Medicinal Chemistry and Lead Discovery, Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland., Kruse AC; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA. Andrew_Kruse@hms.harvard.edu., Kahne D; Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA. kahne@chemistry.harvard.edu.

Publikováno v: Nature [Nature] 2024 Jul; Vol. 631 (8022), pp. E18.

Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period

Autor: Lazor-Blanchet, C. Zygoura, P. Dafni, U. Lamoth, F. Tsourti, Z. Lobritz, M. A. Regina, J. Grandbastien, B. Fenwick, C. Pantaleo, G. Calandra, T. Meylan, S. D.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::0cb0de217b2c599d50a42cdb8186d2a2
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3202251

Molecular docking of eleven snake venom peptides targeting human immunodeficiency virus capsid glycoprotein as inhibitors.

Autor: Germoush, Mousa O.¹ mogermoush@ju.edu.sa, Fouda, Maged¹, Mantargi, Mohammad J. S.², Sarhan, Moustafa^3,4, Alrashdi, Barakat M.¹, Massoud, Diaa¹, Alzwain, Sarah¹, Ghaboura, Nehmat⁵, Altyar, Ahmed E.^6,7, Abdel-Daim, Mohamed M.^2,8

Publikováno v: Open Veterinary Journal. 2024, Vol. 14 Issue 11, p2936-2949. 14p.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Extracellular vesicle isolation methods identify distinct HIV‐1 particles released from chronically infected T‐cells.

Autor: Molnar, Sebastian M.^1,2,3 (AUTHOR), Kim, Yuriy³ (AUTHOR), Wieczorek, Lindsay^1,2 (AUTHOR), Williams, Anastasia³ (AUTHOR), Patil, Kajal Ashok³ (AUTHOR), Khatkar, Pooja³ (AUTHOR), Santos, Mark F.⁴ (AUTHOR), Mensah, Gifty³ (AUTHOR), Lorico, Aurelio⁴ (AUTHOR), Polonis, Victoria R.¹ (AUTHOR), Kashanchi, Fatah³ (AUTHOR) fkashanc@gmu.edu

Publikováno v: Journal of Extracellular Vesicles. Jul2024, Vol. 13 Issue 7, p1-31. 31p.